Primary Antitumor Immune Response Mediated by CD4+ T Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Primary Antitumor Immune Response Mediated by CD4+ T Cells

Published:2005-03 Issue:3 Volume:22 Page:371-383
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Corthay Alexandre,Skovseth Dag K.,Lundin Katrin U.,Røsjø Egil,Omholt Hilde,Hofgaard Peter O.,Haraldsen Guttorm,Bogen Bjarne

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference40 articles.

1. Tumor necrosis factor or tumor promoting factor?;Balkwill;Cytokine Growth Factor Rev.,2002

2. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies;Bingle;J. Pathol.,2002

3. Cancer risk after renal transplantation in the Nordic countries, 1964–1986;Birkeland;Int. J. Cancer,1995

4. Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules;Bogen;Eur. J. Immunol.,1986

5. Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities;Bogen;Eur. J. Immunol.,1992

Cited by 363 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity Through B Cell Antigen Presentation;2024-07-19

2. Deciphering CD4⁺ T cell‐mediated responses against cancer;Molecular Carcinogenesis;2024-05-09

3. High production of IL-12 by human dendritic cells stimulated with combinations of pattern-recognition receptor agonists;npj Vaccines;2024-05-03

4. Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer;Cancer Letters;2024-04

5. Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity;Molecular Therapy: Oncology;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3